The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. [1] It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports. [1] In 2017 about 30% of Swiss exports (worth $84.8 billion) were chemical products. [2] In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion. [3]
Switzerland is home to many pharmaceutical companies, including very large groups, such as Novartis and Hoffmann-La Roche. In 2013, 41 life science companies had their international headquarters (and 29 more their regional headquarters) in Switzerland. [4] [5]
A number of pharmaceutical companies are headquartered in Switzerland:
Additionally, several non-domestic pharmaceutical companies have regional headquarters in Switzerland, including:
Finally, other companies with relevant international activities in Switzerland are:
70% of the investments in life sciences in Europe are made in the United Kingdom, Germany, Ireland, the Netherlands, France, and Switzerland. [4] [5]
In addition to pharmaceutical companies (65 companies), Switzerland is home to many companies in the fields of biotechnology (338 companies) or medical devices and technology (341 companies). [4] [5] According to KPMG, there are 120 life science companies in Basel, 132 in Zürich and 92 in the Lemanic region. [4] [5]
In 2013, 41 life science companies had their international headquarters (and 29 more their regional headquarters) in Switzerland. [4] [5] In Switzerland, there are about 51,000 workers in the field of medical technologies (1,600 companies) and 13,700 on the field of biotechnologies. [8]
According to Le Temps, there are about 900 pharmaceutical and medtech companies (50,000 workers) in the region of Basel. [8] The region of Zurich, mainly active in medical technologies employs 21,000 workers. [8]
According to L'Hebdo, there are 750 biotech and medtech companies (20,000 employees) in the Lemanic region. [9] Among them, 450 companies develop and/or produce drugs. [9] In addition to that, there are 500 laboratories from universities and university hospitals (in the Lemanic region). [9]
The pharmaceutical industry in Switzerland directly and indirectly employs about 135,000 people. [1] It contributes 5.7% of the gross domestic product of Switzerland and 30% of the country's exports. [1] In 2017 about 30% of Swiss exports (worth $84.8 billion) were chemical products. [2] In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion. [3]
Switzerland is home to many pharmaceutical companies, including very large groups, such as Novartis and Hoffmann-La Roche. In 2013, 41 life science companies had their international headquarters (and 29 more their regional headquarters) in Switzerland. [4] [5]
A number of pharmaceutical companies are headquartered in Switzerland:
Additionally, several non-domestic pharmaceutical companies have regional headquarters in Switzerland, including:
Finally, other companies with relevant international activities in Switzerland are:
70% of the investments in life sciences in Europe are made in the United Kingdom, Germany, Ireland, the Netherlands, France, and Switzerland. [4] [5]
In addition to pharmaceutical companies (65 companies), Switzerland is home to many companies in the fields of biotechnology (338 companies) or medical devices and technology (341 companies). [4] [5] According to KPMG, there are 120 life science companies in Basel, 132 in Zürich and 92 in the Lemanic region. [4] [5]
In 2013, 41 life science companies had their international headquarters (and 29 more their regional headquarters) in Switzerland. [4] [5] In Switzerland, there are about 51,000 workers in the field of medical technologies (1,600 companies) and 13,700 on the field of biotechnologies. [8]
According to Le Temps, there are about 900 pharmaceutical and medtech companies (50,000 workers) in the region of Basel. [8] The region of Zurich, mainly active in medical technologies employs 21,000 workers. [8]
According to L'Hebdo, there are 750 biotech and medtech companies (20,000 employees) in the Lemanic region. [9] Among them, 450 companies develop and/or produce drugs. [9] In addition to that, there are 500 laboratories from universities and university hospitals (in the Lemanic region). [9]